This course is aimed at those working as a business development manager, a technology transfer professional, investment analyst, innovation funder, entrepreneur or researcher actively involved in translation and commercialisation.
There are a limited the number of participants to just 40 to optimize networking and learning opportunities. Participants are encouraged to bring along their real-life challenges to the 'surgery sessions' to talk through with experts and peers who can help find a solution. Further details.
View the Course Programme (PDF)
Why attend?
Speakers: All are senior professionals with specialised expertise in this field, including; investors, entrepreneurs, CEOs, pharma heads of R&D, or regulatory experts.
Optimised Learning: Attendance is limited to 40 individuals to foster deeper interaction and valuable networking-building opportunities.
Surgery Sessions: Share your real-life challenges to benefit from community feedback and expert advice.
Unique Content: Learn about different business models and partnerships, the evolving regulatory framework, clinical adoption and open source software licensing.
Registration deadline: 11 September 2018
